Clinical Trial Update: β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating a beta-adrenergic blocker plus a COX-2 inhibitor to prevent recurrence of colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• COX-2 inhibitor (COX-2 inhibitor)
• β-adrenergic blocker

Snippet

Sponsor: Sheba Medical Center | Conditions: Colorectal Neoplasms | Phase 3 | Status: UNKNOWN